A proposal should make clear what decision it helps and what will be delivered. The commercial map distinguishes three early scopes: an evidence decision report, analysis of an existing dataset and coordination of a partner study. They overlap in expertise, but they are not interchangeable purchases.
Compare the unit of work
An Evidence Sprint concerns one question or asset. Data Review concerns one modality and agreed comparisons. Study Desk concerns a defined outsourced research scope, with laboratory charges separate. Ask every provider to state the inputs, exclusions and conditions under which the quote changes.
Check qualifications and capacity
Name the reviewer or analyst whose expertise matches the task. A polished website is not proof of delivery capability. A data project needs authorized access and technical qualification; a laboratory study needs a written scope, quote, capacity and repeat policy. Karam uses those as release conditions for proposed engagements.
Price the complete delivery
Do not compare a $199/month academic software listing, a per-sample assay price and a reviewed decision report as identical products. Each buys a different combination of access, analysis and responsibility. All Karam prices here are planning tests, not verified customer willingness to pay.
Ask for a useful acceptance test
The buyer should name the decision, deadline and useful answer. Require the source trail, reproducible analysis where appropriate and a clear statement of limitations. An unfavorable conclusion should not automatically mean the work failed. Conversely, a favorable story with no inspectable support should not pass merely because it is encouraging.
Treat large industry deals as context
The map cites BioAge’s Novartis agreement as an example of a differentiated data platform supporting a research partnership: up to $20m upfront/research funding and much larger contingent milestones. That is not a Karam revenue forecast, customer relationship or template price. A valuable contract follows a credible asset, evidence and rights.
The practical takeaway: The best comparison is the same decision, the same delivery boundary and the same acceptance test—not the smallest headline number.